Strides Pharma's Chestnut Ridge unit in New York classified as voluntary action indicated by USFDA

Strides Pharma Science announced its US subsidiary, Strides Pharma Inc, has received a Voluntary Action Indicated classification from the USFDA. This follows an inspection of its formulations unit in Chestnut Ridge, New York. The inspection covered Good Manufacturing Practices and drug-device combination capabilities. The facility supports the US market with various product types.